About Us
About Guard Therapeutics
Vision and strategy
The Board
Management
Research & Development
Acute kidney injury
ROSgard
Scientific concept
Clinical development
Patents
Publications
Investor Relations
Financial calender
Financial reports
Event calender
Share information
Corporate governance
Articles of association
Certified Adviser
News & Media
Press releases
Reports and presentations
News
Subscribe
Contact
Swe
Search
Event calender
05 Nov 2019
/
The American Society of Nephrology (ASN) has selected preclinical studies of the drug candidate ROSgard™ for presentation at the organization's International Congress Kidney Week in Washington
Link to ASN Kidney week 5-10 november